The reported statements, read against the company's own industry.
What stands out
Earnings significantly exceed cash generation
Financials view
Market Capitalization
10.06BCNY
1.51B · vs all stocks (USD)
Updated Oct 21, 2026
Trailing P/E
108.64x
vs Scientific & Technical Instruments peers
Updated Oct 21, 2026
Revenue (TTM)
835.00MCNY
125.08M · vs all stocks (USD)
Updated Oct 21, 2026
Profit Margin
10.69%
vs Scientific & Technical Instruments peers
Updated Oct 21, 2026
Beta
1.06x
vs all stocks
Updated Oct 21, 2026
52-Week Change
47.60%
vs all stocks
Updated Oct 21, 2026
Market Capitalization
10.06BCNY
1.51B · vs all stocks (USD)
Updated Oct 21, 2026
Enterprise Value
9.74BCNY
1.46B · vs all stocks (USD)
Updated Oct 21, 2026
Trailing P/E
108.64x
vs Scientific & Technical Instruments peers
Updated Oct 21, 2026
Forward P/E
54.32x
vs Scientific & Technical Instruments peers
Updated Oct 21, 2026
Price to Sales (TTM)
12.04x
vs Scientific & Technical Instruments peers
Updated Oct 21, 2026
Price to Book (MRQ)
5.61x
vs Scientific & Technical Instruments peers
Updated Oct 21, 2026
Enterprise to Revenue
11.66x
vs Scientific & Technical Instruments peers
Updated Oct 21, 2026
Enterprise to EBITDA
73.92x
vs Scientific & Technical Instruments peers
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 72.37×.Updated Oct 21, 2026
Gross Margin
51.09%
vs Scientific & Technical Instruments peers
Updated Oct 21, 2026
Profit Margin
10.69%
vs Scientific & Technical Instruments peers
Updated Oct 21, 2026
Operating Margin
16.19%
vs Scientific & Technical Instruments peers
Updated Oct 21, 2026
Return on Assets (TTM)
3.06%
vs Scientific & Technical Instruments peers
Updated Oct 21, 2026
Return on Equity (TTM)
5.71%
vs Scientific & Technical Instruments peers
Updated Oct 21, 2026
Revenue (TTM)
835.00MCNY
125.08M · vs all stocks (USD)
Updated Oct 21, 2026
Revenue per Share (TTM)
2.28CNYUpdated Oct 21, 2026
Quarterly Revenue Growth
67.60%
vs Scientific & Technical Instruments peers
Updated Oct 21, 2026
Gross Profit (TTM)
431.01MCNY
64.57M · vs all stocks (USD)
Updated Oct 21, 2026
EBITDA (TTM)
134.58MCNY
20.16M · vs all stocks (USD)
Updated Oct 21, 2026
Net Income (TTM)
89.27MCNY
13.37M · vs all stocks (USD)
Updated Oct 21, 2026
Quarterly Earnings Growth (YoY)
405.80%
vs Scientific & Technical Instruments peers
Updated Oct 21, 2026
Operating Cash Flow (TTM)
-20.26MCNY
-3.03M · vs all stocks (USD)
Updated Oct 21, 2026
Levered Free Cash Flow (TTM)
-102.17MCNY
-15.31M · vs all stocks (USD)
Updated Oct 21, 2026
5-Year Average Dividend Yield
0.33%
vs all stocks
Updated Oct 21, 2026
Payout Ratio
0.00%
vs Scientific & Technical Instruments peers
Updated Oct 21, 2026
Minority Interest (Equity)
14.79MCNYFY2025 · Dec 31, 2025
Revenue
670.22MCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
302.07MCNYFY2025 · Dec 31, 2025
Gross Profit
368.15MCNYFY2025 · Dec 31, 2025
Operating Income
92.74MCNY
13.89M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
38.44MCNYFY2025 · Dec 31, 2025
Income Tax Expense
-3.77MCNYFY2025 · Dec 31, 2025
Net Income
42.21MCNYFY2025 · Dec 31, 2025
EBIT
62.18MCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
134.58MCNYFY2025 · Dec 31, 2025
Research & Development
110.95MCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
70.63MCNYFY2025 · Dec 31, 2025
Other Operating Expenses
7.13MCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
6.25MCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
23.74MCNYFY2025 · Dec 31, 2025
EPS (Basic)
0.1100CNYFY2025 · Dec 31, 2025
EPS (Diluted)
0.1100CNYFY2025 · Dec 31, 2025
Basic Shares Outstanding
366.20MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
366.20MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
42.21MCNYFY2025 · Dec 31, 2025
Minority Interests (P&L)
-1.92MCNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
-49.57MCNYFY2025 · Dec 31, 2025
Free Cash Flow
-88.69MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
474.92MCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
42.21MCNYFY2025 · Dec 31, 2025
Other Non-cash Items
20.99MCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
-84.33MCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
-28.43MCNYFY2025 · Dec 31, 2025
Capital Expenditures
-39.12MCNYFY2025 · Dec 31, 2025
Purchase of Investments
-12.20MCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
-51.32MCNYFY2025 · Dec 31, 2025
Long-term Debt Issuance
66.62MCNYFY2025 · Dec 31, 2025
Long-term Debt Payments
-22.23MCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-22.05MCNYFY2025 · Dec 31, 2025
Other Financing Charges
-25.47MCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
-3.13MCNYFY2025 · Dec 31, 2025
Shares Outstanding
370.22MSharesUpdated Oct 21, 2026
Float Shares
224.06MSharesUpdated Oct 21, 2026
% Held by Insiders
40.50%
vs all stocks
Updated Oct 21, 2026
% Held by Institutions
5.92%
vs all stocks
Updated Oct 21, 2026
Total Cash (MRQ)
424.10MCNY
63.53M · vs all stocks (USD)
Updated Oct 21, 2026
Total Cash per Share (MRQ)
1.15CNYUpdated Oct 21, 2026
Total Debt (MRQ)
92.63MCNY
13.88M · vs all stocks (USD)
Updated Oct 21, 2026
Total Debt to Equity (MRQ)
0.0512x
vs Scientific & Technical Instruments peers
Updated Oct 21, 2026
Current Ratio (MRQ)
4.74x
vs Scientific & Technical Instruments peers
Updated Oct 21, 2026
Book Value per Share (MRQ)
4.84CNYUpdated Oct 21, 2026
Total Assets
2.05BCNY
307.15M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
1.38BCNYFY2025 · Dec 31, 2025
Total Liabilities
725.04MCNYFY2025 · Dec 31, 2025
Total Non-current Assets
673.60MCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
447.96MCNYFY2025 · Dec 31, 2025
Total Current Liabilities
277.08MCNYFY2025 · Dec 31, 2025
Cash
474.92MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
474.92MCNYFY2025 · Dec 31, 2025
Accounts Receivable
412.45MCNYFY2025 · Dec 31, 2025
Inventory
350.96MCNYFY2025 · Dec 31, 2025
Accounts Payable
94.75MCNYFY2025 · Dec 31, 2025
Short-term Debt
76.33MCNYFY2025 · Dec 31, 2025
Other Current Liabilities
16.96MCNYFY2025 · Dec 31, 2025
Long-term Debt
426.37MCNYFY2025 · Dec 31, 2025
Other Non-current Liabilities
1.45MCNYFY2025 · Dec 31, 2025
Common Stock (Book)
352.83MCNYFY2025 · Dec 31, 2025
Retained Earnings
328.71MCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
1.33BCNY
198.54M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Treasury Stock
21.93MCNYFY2025 · Dec 31, 2025
52-Week Low
15.09CNYUpdated Oct 21, 2026
52-Week High
46.40CNYUpdated Oct 21, 2026
52-Week Change
47.60%
vs all stocks
Updated Oct 21, 2026
Beta
1.06x
vs all stocks
Updated Oct 21, 2026
50-Day MA
30.98CNYUpdated Oct 21, 2026
200-Day MA
31.26CNYUpdated Oct 21, 2026
Avg 10-Day Volume
10.46MSharesUpdated Oct 21, 2026
Avg 30-Day Volume
10.79MSharesUpdated Oct 21, 2026
Diluted EPS (TTM)
0.2500CNYUpdated Oct 21, 2026
1 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.